期刊文献+

透明质酸修饰壳聚糖/pDNA纳米微球的制备及体外转染软骨细胞 被引量:6

Preparation of hyaluronic acid modified chitosan/pDNA nanoparticles and transfection of chondrocytes in vitro
原文传递
导出
摘要 目的以透明质酸(HA)修饰基因载体壳聚糖(CS)纳米微球,制作一种新型的HA/CS/pDNA基因转染系统,观察其结构特征及体外对软骨细胞的转染能力。方法将不同比例的HA和CS与负载增强型绿色荧光蛋白基因(EGFP)的质粒DNA(pDNA)以复凝聚法制成纳米微球,以扫描电镜检测纳米微球形态,Zeta电位粒度分析仪测定其粒径、表面电位;凝胶电泳阻滞实验观察CS和pDNA的结合力;体外转染兔关节软骨细胞,以流式细胞仪及荧光显微镜检测转染效率。结果HA/CS/pDNA纳米微球多呈球形,粒径为(223±51)mm,表面Zeta电位为(17.4±6.1)mV,可有效保护pDNA免受DNaseⅠ的降解。体外转染实验证明HA/CS/pDNA纳米微球能介导pEGFP转染软骨细胞并在细胞内表达绿色荧光蛋白,转染率达(15.450±0.404)%,比裸pDNA组和CS/pDNA组有更高的转染效率(P〈0.05)。结论复凝聚法制备的HA/CS/pDNA纳米微球是一种有效的新型非病毒基因转染系统,对软骨细胞有着潜在的靶向基因转染能力。 Objective To prepare hyaluronic acid (HA) -modified ehitosan ( CS)/pDNA ( HA/ CS/pDNA) nanoparticles as novel gene vectors, study their structural characteristics and gene transfection efficiency for chondrocytes in vitro in rabbits. Methods The HA/CS/pDNA nanoparticles were prepared by a complex coacervation method with different ratios of HA: CS mixed with plasmid DNA (pDNA) , which load enhanced green fluorescent protein (EGFP) gene. The morphology of the nanoparticles was observed under the transmission electron microscopy. The sizes and zeta-potentials of the nanoparticles were measured by a Marven-nano laser diffractometer. The binding of pDNA was evaluated by agarose gel electrophoresis analysis. The gene transfection experiments in vitro were performed with the chondrocytes of rabbits. The gene transfection efficiency was measured by using flow eytometry and under the fluorescence microscopy. Results HA/CS/pDNA nanoparticles were mainly spherical, with an average size of (223 ± 51 )nm, and zeta-potential of ( 17.4 ± 6. 1 ) mV. The agarose gel electrophoresis analysis confirmed that they could effectively protect pDNA from degradation against DNase Ⅰ. Gene transfection in vitro proved that HA/CS/pDNA nanoparticles could be efficiently transfected into chondrocytes of rabbits, the expression of green fluorescent proteins was observed under the fluorescent microscopy, and the transfection efficiency reached as high as ( 15. 450 ±0. 404 ) % , significantly higher than that of the naked pDNA or the CS/pDNAnanoparticles (P 〈 0. 05 ). Conclusion HA/CS/pDNA nanoparticles were an effective novel non-viral gene transfer vector, which possessed the potential targeting transfection ability on chondrocytes.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2011年第7期1029-1032,共4页 Chinese Journal of Experimental Surgery
基金 国家自然科学基金资助项目(30600632) 广东省科技计划资助项目(2010B060900029)
关键词 壳聚糖 透明质酸 基因载体 转染 软骨细胞 Chitosan Hyaluronic acid Gene vector Transfection Chondrocyte
  • 相关文献

参考文献10

  • 1Zheng F,Shi XW,Yang GF,et al.Chitosan nanoparticle as gene therapy vector via gastrointestinal mucosa administration:results of an in vitro and in vivo study.Life Sci,2007,80:388-396.
  • 2Lavertu M,Methot S,Tran-Khanh N,et al.High efficiency gene transfer using chitosan/DNA nanoparticles with specific combinations of molecular weight and degree of deacetylation.Biomaterials,2006,27:4815-4824.
  • 3Chow G,Nietfeld JJ,Knudson CB,et al.Antisense inhibition of chondrocyte CD44 expression leading to cartilage chondrolysis.Arthritis Rheum,1998,41:1411-1419.
  • 4Li SD,Huang L.Targeted delivery of antisense oligodeoxynucleotide and small interference RNA into lung cancer cells.Mol Pharm,2006,3:579-588.
  • 5刘克敏,陈维均.透明质酶关节内注射治疗骨关节炎[J].中华实验外科杂志,1993,10(4):164-165. 被引量:8
  • 6金伟,陈廖斌,汪晖.丹参和透明质酸钠局部给药对兔骨关节炎的影响[J].中华实验外科杂志,2005,22(7):847-848. 被引量:17
  • 7Baragi VM,Renkiewicz RR,Jordan H,et al.Transplantation of transduced chondrocytes protects articular cartilage from interleukin 1-induced extracellular matrix degradation.J Clin Invest,1995,96:2454-2460.
  • 8de la Fuente M,Seijo B,Alonso MJ.Novel hyaluronic acid-chitosan nanoparticles for ocular gene therapy.Invest Ophthalmol Vis Sci,2008,49:2016-2024.
  • 9Ito T,Iida-Tanaka N,Niidome T,et al.Hyaluronic acid and its derivative as a multi-functional gene expression enhancer:protection from non-specific interactions,adhesion to targeted cells,and transcriptional activation.J Control Release,2006,112:382-388.
  • 10Douglas KL,Piccirillo CA,Tabrizian M.Effects of alginate inclusion on the vector properties of chitosan-based nanoparticles.J Control Release,2006,115:354-361.

二级参考文献8

共引文献22

同被引文献49

  • 1向川,杜靖远,翁习生,卫小春.转化生长因子-β1基因和胰岛素样生长因子1基因联合转染治疗兔膝骨性关节炎的研究[J].中华实验外科杂志,2005,22(12):1540-1542. 被引量:20
  • 2李兵,吴志宏,刘广源,肖军,韩东,邱贵兴.三种软骨细胞分离培养方法对细胞骨架的影响比较[J].中华实验外科杂志,2007,24(9):1108-1110. 被引量:8
  • 3Wang D,Gong X,Heeger PS,et al. Biosensors from conjugated poly-electrolyte complexes. Proc Natl Acad Sci U S A ,2008,99:49-53.
  • 4Richards Grayson AC,Choi IS,Tyler BM,et al. Multi-pulse drug de-livery from a resorbable polymeric microchip device. Nat Mater, 2003,2:767-772.
  • 5Linhardt RJ. 2003 Claude S. Hudson Award address in carbohydratechemistry. Heparin : structure and activity. J Med Chem, 2003 , 46 :2551-2564.
  • 6Chung YI,Tae G,Hong Yuk S. A facile method to prepare heparin-functionalized nanoparticles for controlled release of growth factors.Biomaterials,2006,27 : 2621 -2626.
  • 7Ai H, Jones SA,Lvov YM. Biomedical applications of electrostatic lay-er-by-layer nano-assembly of polymers,enzymes,and nanoparticles.Cell Biochem Biophys,2003,39 :23 -43.
  • 8Ma W,Chen M,Kaushal S,et ai. PLGA nanoparticle-mediated deliv-ery of tumor antigenic peptides elicits effective immune responses. IntJ Nanomedicine,2012,7 : 1475-1487.
  • 9Cohen-Sela E,Teitlboim S,Chomy M,et al. Single and double emul-sion manufacturing techniques of an amphiphilic drug in PLGA nano-particles :formulations of mithramycin and bioactivity. J Pharm Sci,2009,98:1452-1462.
  • 10Bilati U,All6mann E,Doelker E. Poly ( D,L-lactide-co-glycolide )protein-loaded nanoparticles prepared by the double "emulsion meth-od-processing and formulation issues for enhanced entrapment effi-ciency. J Microencapsul,2005,22 :205-214.

引证文献6

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部